# The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux

> **NCT00324974** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 162 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Lansoprazole microgranules suspension
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00324974
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2010-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324974, "The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00324974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*